The charge distribution of aerosol is an important factor for accurate prediction of aerosol behavior as it influences particle transport, settling, deposition, and coagulation. In the production of aerosol for pulmonary drug delivery, charging of aerosol particles is influenced by both the generation method and chemical properties of the drug. Electrostatic charging of add-on devices such as plastic spacers and holding chambers will reduce the delivery to the lung, while charged particles can also enhance deposition to the respiratory system by inducing an image charge to airway surfaces. Typical target particle size for delivery devices in terms of mass median aerodynamic diameter (MMAD) is 1-5 μm, and therefore up to 50% of the dose includes submicron particles in the fine (100-1000 nm) and ultrafine ( < 100 nm) size range. Measurement of the charge distribution of submicron particles produced using a vibrating mesh nebulizer is presented using a tandem differential mobility analyzer (TDMA). It is found that the charge distribution is not at equilibrium, but instead has an increase in the fraction of charged particles below 200 nm and a decrease in the charged fraction above 200 nm. In general the charge distribution will be dependent on the specific aerosol nebulizer setup being used and the chemical properties of the nebulized solution, and it could be further quantified by using the methods discussed here.
Introduction
An aerosol is a suspension of particles or droplets in a gaseous phase. Aerosolized drugs (suspension of drug particles or droplets in air) are administered through use of several devices that include metered dose inhalers, spacers and holding chambers, dry powder inhalers, and nebulizers. Once the drug is aerosolized, the evolution of the drug particles or droplets as they proceed through inhalation pathways is affected by their properties and the environment. The important parameters in this are the aerosol (we use this designation for mainly particles and droplets, although often this designation is used to include suspending gas also) properties such as size, density, surface tension, composition, charge, and humidity, geometry of flow, and flow rates. Advances in understandings in many of these areas have led to successful drugs and delivery devices that now enable delivery of desired amounts to targeted areas in distal lung and proximal airways. Recent changes have improved performance in all four categories of devices: metered dose inhalers (1, 2) , spacers and holding chambers (1, 3, 4) , dry powder inhalers (5) , and nebulizers (4, 6, 7) . A review of the recent progress in devices can be found in Dolovich and Dhand (8) .
Nanoparticles present an attractive delivery mechanism for pharmaceuticals due to increased solubility and dissolution rates in drug formulations (9, 10) . Delivering nanoparticles to the respiratory system includes additional advantages such as the ability to escape clearance by macrophages and mucus entanglement (11) (12) (13) , improved systemic bioavailability and more rapid onset of therapeutic action (14, 15) , controlled and prolonged drug release (12, 16, 17) , increased absorption rates (18) , and cell specific targeted delivery at cellular and organ levels (12, 16) . Furthermore, nanoparticles have potential in targeting the olfactory region to provide drug delivery to the central nervous system for a wide range of neurological disorders such as Parkinson's and Alzheimer's disease (19, 20) , as well as targeting drug delivery to alveolar macrophages for treatment of tuberculosis (12, 17, 21) .
Typical delivery devices produce aerosol with mass median aerodynamic diameter (MMAD) in the range of 1-5 μm. For a MMAD of 1 μm this means that 50% of the delivered dose will be in the form of submicron particles. Particles in the size range of 40-1000 nm are known to have very low deposition fractions in the oral and nasal extrathoracic airways which reduces depositional losses and associated side effects (22) . Ultrafine particles have been reported to have deposition efficiencies up to 50% in the alveolar region after slow inhalation with a breath hold, as well as high deposition efficiencies in the total respiratory tract with greater deposition in subjects with asthma or chronic obstructive pulmonary disease (15) . Some methods are available for delivery of submicron particles, for example pressurized steroid formulations HFA ciclesonide and HFA BDP (23), however practical implementation of the delivery of ultrafine particles is limited by the lack of convenient devices for directly generating nanosized aerosol (22) . Two reported methods, enhanced condensational growth (ECG) and excipient enhanced growth (EEG), utilize common nebulizers with add-on devices to dry the particles to submicron sizes. The ECG method delivers the submicron aerosol with a conditioned airstream of elevated temperature and relative humidity, while the EEG utilizes hygroscopic particles. Both methods deliver submicron particles for negligible extrathoracic deposition and promote condensational growth downstream to increase particle size and enhanced deposition efficiency in the lung (22) .
Particle charge has been identified as an important parameter for predicting particle deposition in airways (15, 24) . For example, electrostatic charging of add-on devices such as plastic spacers and holding chambers is known to reduce the delivery to the lung (8, 23, 25) , conversely charged particles can also enhance deposition to the respiratory system by inducing an image charge to airway surfaces (26) . A knowledge of charge distribution is therefore important for accurate prediction of aerosol behavior as it influences particle transport, settling, deposition, and coagulation (27) (28) (29) . For pulmonary drug delivery this would provide additional information needed to increase lung penetration and delivery efficiency through optimization of pharmaceutical formulations, nebulizers and support equipment (8, 15, 25, 26, (30) (31) (32) (33) . Measurement of charge distribution has been reported for micron sized particles where optical measurement techniques are applicable (30) , however measurements are lacking for the fine and ultrafine fractions of delivered aerosol. In this work, in what appear to be the first measurements of size and charge distribution of liquid aerosols (and in particular, for such devices), we demonstrate the measurement of the size and charge distribution of a submicron aerosol generated by an Aeroneb Pro ® vibrating mesh nebulizer operated with normal saline using a tandem differential mobility analyzer (TDMA). Measurements are first performed with a radioactive charge neutralizer to confirm the accuracy of the TDMA and data processing method by comparing the results against theoretical equilibrium charge distributions. Measurements are then repeated without a charge neutralizer to determine the charge distribution as generated by the vibrating mesh nebulizer, and the results are compared to theoretical equilibrium charge distributions to examine the deviation from equilibrium.
Method
A typical patient application of the pharmaceutical nebulizer was simulated using the Aeroneb Pro ® vibrating mesh nebulizer with the adult sized T-piece supplied by Aerogen ® as depicted in Figure 1 . Two lengths of pipe (3/4 NPS Sch. 40 PVC) were connected to the T-piece to represent a respiratory circuit. Airflow into the nebulizer setup was supplied via a diaphragm compressor (GAST DOL-101-AA) at a flow rate of 15 LPM. The supplied air was also dried using two laboratory drying units (DRIERITE # 26800) and filtered using a HEPA filter (TSI #1602051). Using dry, filtered air provided a consistent air supply over long periods of time by preventing variations in humidity due to changing laboratory conditions which could otherwise lead to changes in droplet evaporation rates. In this study a normal saline solution (0.90% w/v of NaCl) prepared using ≥ 99.5% sodium chloride (Fisher Scientific enzyme grade BP358) and 18 MΩ deionized water (Thermo Scientific NERL Reagent Grade) was used to produce salt nuclei aerosol. During operation the nebulized sample was transported by the clean airflow past a sharp-edged, thin-wall sampling probe (1/4 in. OD) located 200 mm downstream from the nebulizer before being vented freely to the atmosphere. The sampled aerosol was immediately conditioned using a diffusion dryer to ensure that the nebulized droplets were completely evaporated to form single salt nuclei. Beyond the diffusion dryer the aerosol was transported, using conductive tubing, to either a tandem differential mobility analyzer (TDMA) or a scanning mobility particle sizer (SMPS) for characterization.
Charge distribution measurements of dry ultrafine aerosols using the TDMA technique have been reported by several authors (34) (35) (36) . The TDMA used in this study was comprised of a TSI 3080 Electrostatic Classifier with a TSI 3081 Long DMA and a TSI 3936 Scanning Mobility Particle Sizer ™ spectrometer consisting of a TSI 3080 Electrostatic Classifier with a TSI 3081 Long DMA and TSI 3775 Condensation Particle Counter. The TDMA data was analyzed using a custom algorithm created in Mathematica ® following the data reduction procedures described by Kim et al. (34) . However, instead of stepping DMA-1 based on specific equivalent electrical mobility diameters, DMA-1 was stepped such that singly charged particles were centered on each size bin of the SMPS. In this way, due to the width of the transfer function and a resolution of 64 bins/ decade, each size bin was part of multiple measurements, either due to singly charged particles and/or multiply charged particles as DMA-1 was stepped from high to low electrical mobilities (i.e., low to high voltages). Although this method greatly increases total measurement time, multiple measurements at each size bin for changing DMA-1 parameters allowed for the use of the least squares method to resolve the contributions of multiple charge levels at each size bin (37) . To verify the measurement method and data reduction procedure an additional charge neutralizer was used to bring the aerosol to charge equilibrium for comparison with theory. Since theoretical charge distributions are represented in terms of charge fraction, the SMPS was used to obtain the total size distribution for normalization. Figure 2 shows the four different experimental configurations used in this study in measuring the charge distributions for nebulized and charged neutralized aerosols.
The TSI Aerosol Instrument Manager ® (AIM) software was used to control the SMPS and to obtain size distributions from built-in inversion algorithms. A custom setting and for the new selection of equivalent electrical mobility particles to reach the SMPS. The process was repeated for a predetermined number of scans corresponding to the number of size bins measured by the SMPS. This process was repeated for both positively and negatively charged particles by switching the polarity of the high voltage module in DMA-1. Corrections for multiply charged particles and diffusion losses in the SMPS were also accounted for within the AIM software along with variations in temperature and pressure within DMA-2. (28), respectively. A summary of instrument settings and parameters used throughout this study are presented in Table 1 .
Results/discussion
The charge neutralized results shown in Figure 3 have been analyzed up to ± 4 units of charge and show good agreement with the corrected Fuchs charge distribution given by the Wiedensohler approximation (39) . As predicted by the Fuchs model, the fraction of negatively charged particles exceeds the fraction of positively charged particles at all charge levels. However, the measured distributions do not indicate the magnitude in spread between polarities as predicted by Fuchs' theory and the fractions of positively and negatively charged particles at each charge level converge above 200 nm. This convergence follows the Boltzmann equilibrium charge distribution model for ± 2, ± 3 and ± 4 units of charge, while the fraction of singly charged particles above 200 nm falls off more rapidly than predicted. The charge distribution of the nebulized aerosol shown in Figure 4 does not follow the equilibrium charge distributions given by either Fuchs or Boltzmann. At all charge levels, the positive charge fraction is less than the negative charge fraction at small diameters and then transitions to a charge fraction greater than the negative charge fraction at larger diameters. Specifically, the transition occurs at approximately 59 nm, 73 nm, 83 nm, and 84 nm for charge levels 1, 2, 3, and 4, respectively. The distributions of ± 2, ± 3 and ± 4 units of charge show an apparent shift to smaller diameters with higher particle concentrations at smaller diameters and lower concentrations at larger diameters as compared to the equilibrium distributions. There is also a sudden decrease and recovery of the positive charge fraction at approximately 28 nm, 40 nm, 50 nm and 57 nm for charges +1, +2, +3, and +4, respectively. All of these diameters correspond to an equivalent electrical mobility of Z p ≈3 × 10 -7 m 2 /V·s for the respective charge level and therefore this anomaly is thought to be due to a momentary decrease in nebulizer output either due to a low reservoir level or a buildup of air bubbles on the mesh screen. Overall, with respect to charge equilibrium, there is an increase in the fraction of charged particles below 200 nm and a decrease in the charged fraction above 200 nm. The absolute charge distribution is shown in Figure 5 with the total size distribution measured by the SMPS to provide an indication of the nebulizer output. The nebulizer generated a broad size distribution irrespective of charge state with particle sizes exceeding the measuring range of the SMPS. Overall the size distribution is smooth and apparently lognormal with a geometric mean and standard deviation of approximately 109 nm and 2.03, respectively.
Conclusion
The charge distribution of aerosol generated by an Aeroneb Pro ® vibrating mesh nebulizer operated with normal saline has been measured using a tandem differential mobility analyzer. The measurement and data analysis techniques where verified by comparing results for charged neutralized aerosol with theoretical equilibrium charge distributions of both Fuchs and Boltzmann. Results for the charged neutralized aerosol show higher concentrations of negatively charged particles over positively charged particles at all charge levels as predicted by Fuchs, however the magnitude of spread between the polarities is not as wide as predicted and more closely follows the Boltzmann distribution.
Results for the nebulized aerosol indicate that the charge distribution is not at equilibrium, but instead has an increase in the fraction of charged particles below 200 nm and a decrease in the charged fraction above 200 nm. In general the charge distribution will be dependent on the specific aerosol nebulizer configuration and the chemical properties of the nebulized solution. For pharmaceutical applications this has direct implications in respirable dose optimization, and as shown here, the TDMA can be used within the submicron particle size range to determine the charge distribution. We recognize that these are the first such measurements of size and charge distributions, and the optimization of respirable dose distribution utilizing charge information will take considerable future efforts and testing for both nebulizers and dry powders inhalers. 
